English
English
简体中文
0760-89920979
Home
About Us
Our Team
Pipeline
News
Company news
Industry news
Join Us
Contact Us
0760-89920979
News
Home
>
News
/
Company news
/
First Subject Enrolled in Phase II Clinical Trial of World's First Osteonecrosis Drug RAB001!
Time:1735111200
Back to list
Previous: Not yet
Next: Not yet
0760-89920979
info@rabpharma.com
